First Manhattan CO Oyster Point Pharma, Inc. Transaction History

First Manhattan CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $937,990 - $2.92 Million	-260,553 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $2.81 Million - $5.78 Million	-327,282 Reduced 55.68%	260,553 $3.03 Million
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $1.46 Million - $2.72 Million	143,346 Added 32.25%	587,835 $10.7 Million
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $854,244 - $1.32 Million	73,200 Added 19.72%	444,489 $5.27 Million
Q1 2021 May 14, 2021	BUY	$17.92 - $25.86 $3.44 Million - $4.96 Million	191,765 Added 106.82%	371,289 $6.79 Million
Q4 2020 Feb 16, 2021	BUY	$18.13 - $25.18 $1.27 Million - $1.76 Million	69,800 Added 63.61%	179,524 $3.38 Million
Q3 2020 Nov 12, 2020	BUY	$17.83 - $29.12 $205,883 - $336,248	11,547 Added 11.76%	109,724 $2.32 Million
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $95,114 - $122,665	3,414 Added 3.6%	98,177 $2.84 Million
Q1 2020 May 06, 2020	BUY	$23.65 - $40.96 $2.24 Million - $3.88 Million	94,763 New	94,763 $3.32 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.